Synthetic cannabinoids are manufactured clandestinely with little quality control and are distributed as herbal spice for smoking or as bulk compound for mixing with a solvent and inhalation via electronic vaporizers. Intoxication with synthetic cannabinoids has been associated with seizure, excited delirium, coma, kidney damage, and other disorders. The chemical alterations produced by heating these structurally novel compounds for consumption are largely unknown. The current study found that some products of combustion retained high affinity, were more efficacious, and were potent in laboratory animals; whereas, other compounds had low affinity and efficacy and were devoid of cannabimimetic activity. Degradants that retained affinity and efficacy also substituted in drug discrimination tests for the prototypical synthetic cannabinoid 1-pentyl-3-(1-naphthoyl)indole (JWH-018), and are likely to produce psychotropic effects in humans. Hence, it is important to take into consideration the actual chemical exposures that occur during use of synthetic cannabinoid formulations to better comprehend the relationships between dose and effect. (Publisher abstract modified)
Downloads
Similar Publications
- How the Work Being Done on Statistical Fingerprint Models Provides the Basis for a Much Broader and Greater Impact Affecting Many Areas within the Criminal Justice System
- Erratum: Specific and Sensitive mRNA Biomarkers for the Identification of Skin in 'Touch DNA' Evidence
- DNA Contamination, Degradation, Damage and Associated Microbiomes: A Comparative Analysis through Massive Parallel Sequencing and Electrophoresis